Retraction notice to "Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammatin" [European Journal of Pharmaceutical Sciences 51C (2013) 26-33]

Eur J Pharm Sci. 2018 Oct 15:123:584. doi: 10.1016/j.ejps.2018.08.039.

¹ Department of Internal Medicine and Therapeutics, University of Pavia, PAVIA, Italy; Center for the Study of Endocrine-Metabolic Pathophysiology and Clinical Research, University of Pavia, PAVIA, Italy. Electronic address: [email protected].
² Aging and Kidney diseases, "G. Descovich" Atherosclerosis Study Center, University of Bologna, BOLOGNA, Italy.
³ Hospital Center of Diabetes, Sant'Angelo Lodigiano, LODI, Italy.
⁴ Ospedale Pesenti Fenaroli, Alzano Lombardo, BERGAMO, Italy.
⁵ Department of Internal Medicine and Therapeutics, University of Pavia, PAVIA, Italy.

No abstract available

Publication types